10-79557289-G-T

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_001098668.4(SFTPA2):​c.667C>A​(p.Gln223Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.211 in 1,613,734 control chromosomes in the GnomAD database, including 38,163 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 5277 hom., cov: 32)
Exomes 𝑓: 0.21 ( 32886 hom. )

Consequence

SFTPA2
NM_001098668.4 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.945

Publications

65 publications found
Variant links:
Genes affected
SFTPA2 (HGNC:10799): (surfactant protein A2) This gene is one of several genes encoding pulmonary-surfactant associated proteins (SFTPA) located on chromosome 10. Mutations in this gene and a highly similar gene located nearby, which affect the highly conserved carbohydrate recognition domain, are associated with idiopathic pulmonary fibrosis. The current version of the assembly displays only a single centromeric SFTPA gene pair rather than the two gene pairs shown in the previous assembly which were thought to have resulted from a duplication. [provided by RefSeq, Sep 2009]
SFTPA2 Gene-Disease associations (from GenCC):
  • interstitial lung disease 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • idiopathic pulmonary fibrosis
    Inheritance: Unknown, AD Classification: MODERATE, LIMITED Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a domain C-type lectin (size 116) in uniprot entity SFPA2_HUMAN there are 7 pathogenic changes around while only 2 benign (78%) in NM_001098668.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0025300682).
BP6
Variant 10-79557289-G-T is Benign according to our data. Variant chr10-79557289-G-T is described in ClinVar as Benign. ClinVar VariationId is 227071.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.366 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SFTPA2NM_001098668.4 linkc.667C>A p.Gln223Lys missense_variant Exon 6 of 6 ENST00000372325.7 NP_001092138.1 Q8IWL1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SFTPA2ENST00000372325.7 linkc.667C>A p.Gln223Lys missense_variant Exon 6 of 6 1 NM_001098668.4 ENSP00000361400.2 Q8IWL1
SFTPA2ENST00000372327.9 linkc.667C>A p.Gln223Lys missense_variant Exon 5 of 5 1 ENSP00000361402.5 Q8IWL1
SFTPA2ENST00000417041.1 linkc.*193C>A downstream_gene_variant 5 ENSP00000397375.1 X6REF7

Frequencies

GnomAD3 genomes
AF:
0.250
AC:
37959
AN:
151766
Hom.:
5265
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.370
Gnomad AMI
AF:
0.135
Gnomad AMR
AF:
0.165
Gnomad ASJ
AF:
0.305
Gnomad EAS
AF:
0.189
Gnomad SAS
AF:
0.268
Gnomad FIN
AF:
0.206
Gnomad MID
AF:
0.294
Gnomad NFE
AF:
0.205
Gnomad OTH
AF:
0.245
GnomAD2 exomes
AF:
0.217
AC:
54596
AN:
251408
AF XY:
0.223
show subpopulations
Gnomad AFR exome
AF:
0.373
Gnomad AMR exome
AF:
0.131
Gnomad ASJ exome
AF:
0.307
Gnomad EAS exome
AF:
0.192
Gnomad FIN exome
AF:
0.212
Gnomad NFE exome
AF:
0.201
Gnomad OTH exome
AF:
0.202
GnomAD4 exome
AF:
0.207
AC:
301937
AN:
1461850
Hom.:
32886
Cov.:
34
AF XY:
0.210
AC XY:
152941
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.385
AC:
12871
AN:
33474
American (AMR)
AF:
0.137
AC:
6125
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.309
AC:
8075
AN:
26136
East Asian (EAS)
AF:
0.196
AC:
7763
AN:
39700
South Asian (SAS)
AF:
0.289
AC:
24887
AN:
86250
European-Finnish (FIN)
AF:
0.215
AC:
11480
AN:
53416
Middle Eastern (MID)
AF:
0.320
AC:
1843
AN:
5768
European-Non Finnish (NFE)
AF:
0.194
AC:
215836
AN:
1111994
Other (OTH)
AF:
0.216
AC:
13057
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
18713
37425
56138
74850
93563
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7550
15100
22650
30200
37750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.250
AC:
38017
AN:
151884
Hom.:
5277
Cov.:
32
AF XY:
0.249
AC XY:
18518
AN XY:
74222
show subpopulations
African (AFR)
AF:
0.370
AC:
15324
AN:
41362
American (AMR)
AF:
0.165
AC:
2524
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.305
AC:
1059
AN:
3472
East Asian (EAS)
AF:
0.188
AC:
975
AN:
5178
South Asian (SAS)
AF:
0.269
AC:
1298
AN:
4818
European-Finnish (FIN)
AF:
0.206
AC:
2174
AN:
10538
Middle Eastern (MID)
AF:
0.299
AC:
88
AN:
294
European-Non Finnish (NFE)
AF:
0.205
AC:
13937
AN:
67932
Other (OTH)
AF:
0.244
AC:
515
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1358
2716
4075
5433
6791
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.229
Hom.:
2278
Bravo
AF:
0.248
TwinsUK
AF:
0.190
AC:
705
ALSPAC
AF:
0.188
AC:
724
ESP6500AA
AF:
0.358
AC:
1576
ESP6500EA
AF:
0.200
AC:
1718
ExAC
AF:
0.222
AC:
26906
EpiCase
AF:
0.215
EpiControl
AF:
0.212

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 06, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26436397, 24950659, 16292672, 23056344, 20466729) -

not specified Benign:1
Nov 26, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Gln223Lys in exon 6 of SFTPA2: This variant is not expected to have clinical s ignificance because it has been identified in 36% (1576/4406) of African America n chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.ed u/EVS/; dbSNP rs1965708). -

Interstitial lung disease 2 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.059
BayesDel_addAF
Benign
-0.88
T
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.20
DANN
Benign
0.30
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0024
N
MetaRNN
Benign
0.0025
T;T
MetaSVM
Benign
-0.90
T
PhyloP100
-0.94
PrimateAI
Benign
0.37
T
PROVEAN
Benign
0.13
N;N
REVEL
Benign
0.014
Sift
Benign
1.0
T;T
Sift4G
Benign
1.0
T;T
Vest4
0.047
MPC
1.3
ClinPred
0.0031
T
GERP RS
-3.2
gMVP
0.50
Mutation Taster
=95/5
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1965708; hg19: chr10-81317045; COSMIC: COSV64882436; COSMIC: COSV64882436; API